In the News

Transforming outcomes in AML and breast cancer: Three open trials at Providence

10/30/2025

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

Oregon cancer leaders unite to discuss research and policy

10/17/2025

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.

10/24/2025

Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

Newly retired lung cancer survivor receives advanced treatment close to home

10/28/2025

Jim waited until he was 70 to retire from a long and fulfilling career. Then he was diagnosed with lung cancer—twice.

Next generation therapy for men with mCRPC may extend survival

9/29/2025

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

Behind the science: Celebrating our cancer research administrator

10/14/2025

Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

Charting new paths in treating ovarian cancer and recurring SCLC

9/26/2025

Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

The future of surgery is robotic, and it’s here

8/14/2025

Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.

Meet the 2025 cancer research interns

8/14/2025

Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.

Watch: Virtual health talk on understanding lung cancer

9/24/2025

Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.

A new cancer therapy at Providence helps immune cells stand their ground

9/25/2025

A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer

9/24/2025

A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

New Study: Providence whole genome sequencing program shows transformative potential for population health

7/1/2025

Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.

Cancer patients in Newberg receive a gift of comfort

6/19/2025

A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.

How cold cap therapy prevented patient’s hair loss during cancer treatment

6/3/2025

What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.

New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

5/28/2025

Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

Providence researchers share cancer discoveries at 2025 ASCO meeting

5/29/2025

Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

9/24/2025

Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

Studies to be presented by Providence researchers at AACR annual meeting

5/13/2025

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

Seeking better treatments for people with ER+/HER- breast cancer

9/24/2025

Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.

From life-saving surgery to back on the slopes: A photographer’s story

2/27/2025

Gary tells his story about the difficult journey back to the slopes of Mt. Hood after receiving life-saving surgery for pancreatic cancer.

Robotic versus open surgery for early cervical cancer

9/24/2025

This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.

A year to remember: Advancements, recognition and transitions

1/2/2025

Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

CAR T cell-therapy, hope and healing: Dean’s story

5/19/2025

Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.

Two clinical trials for solid tumor cancers take different approaches to stop growth

2/18/2025

Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.

Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains

11/14/2024

R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.

2024 SITC Meeting: A glimpse of recent advancements in immunotherapy

11/19/2024

The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.

Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

2/18/2025

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

New studies test immunotherapy to boost breast cancer treatment and prevent return

2/18/2025

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.